Showing results (71-80 of 178) with videos related to
Sort By:
Pageof 18
Cardiorenal Medicine|May 13, 2019
Cardiometabolic-Renal Disease in South Asians: Consensus Recommendations from the Cardio Renal Society of AmericaKrishnaswami Vijayaraghavan, Peter A McCullough, Bhupinder Singh, et al.Cardiac Electrophysiology Review|January 24, 2004
How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF)John Wikstrand, Hans Wedel, Jalal Ghali, et al.American Heart Journal|March 30, 2002
Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal Efficacy and SUrvival Study)John A Spertus, Joseph Tooley, Phil Jones, et al.Stroke|September 22, 2007
Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V TrialsGary A Ford, Anna Maria Choy, Prakash Deedwania, et al.Journal of the American Society of Hypertension : JASH|April 23, 2010
Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid TrialGregg C Fonarow, Prakash Deedwania, Vivian Fonseca, et al.Scientific Reports|May 22, 2024
CMR provides comparable measurements of diastolic function as echocardiographyKana Fujikura, Bharath Sathya, Tushar Acharya, et al.Journal of the American College of Cardiology|January 18, 2005
What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF)Lars Gullestad, John Wikstrand, Prakash Deedwania, et al.The American Journal of Cardiology|October 20, 2019
Sodium Glucose Co-transporter 2 Inhibitors and Heart FailureRaktim K Ghosh, Gopal Chandra Ghosh, Manasvi Gupta, et al.Journal of the American College of Cardiology|April 12, 2008
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) studyJames Shepherd, John J P Kastelein, Vera Bittner, et al.Clinical Journal of the American Society of Nephrology : CJASN|October 19, 2007
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) studyJames Shepherd, John J P Kastelein, Vera Bittner, et al.Pageof 18